StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Trading Up 0.4 %
Shares of RKDA opened at $4.82 on Tuesday. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The company has a market cap of $6.56 million, a P/E ratio of -1.13 and a beta of 0.88. The company’s fifty day simple moving average is $5.45 and its 200-day simple moving average is $3.92.
Arcadia Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Growth Stocks: What They Are, What They Are Not
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What is a Special Dividend?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.